Key Highlights of the Report: Worldwide Growing Cases of Cancer: The growing incidence and prevalence of cancer is the major factor for increasing the demand for CXCR4 antagonists. Increased Focus on Combination Therapies: Combination therapy further improves the effectiveness of CXCR antagonists because it is done in combination with other agents, chemotherapeutic agents or targeted therapies...